Follow
Abid oueslati
Abid oueslati
Centre de Recherche du CHU de Québec-Université Laval
Verified email at crchudequebec.ulaval.ca - Homepage
Title
Cited by
Cited by
Year
The many faces of α-synuclein: from structure and toxicity to therapeutic target
HA Lashuel, CR Overk, A Oueslati, E Masliah
Nature Reviews Neuroscience 14 (1), 38-48, 2013
16972013
Role of post-translational modifications in modulating the structure, function and toxicity of α-synuclein: implications for Parkinson’s disease pathogenesis and therapies
A Oueslati, M Fournier, HA Lashuel
Progress in brain research 183, 115-145, 2010
4322010
Phosphorylation at S87 is enhanced in synucleinopathies, inhibits α-synuclein oligomerization, and influences synuclein-membrane interactions
KE Paleologou, A Oueslati, G Shakked, CC Rospigliosi, HY Kim, ...
Journal of Neuroscience 30 (9), 3184-3198, 2010
3872010
Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?
A Oueslati
Journal of Parkinson's disease 6 (1), 39-51, 2016
3292016
Phosphorylation of synucleins by members of the Polo-like kinase family
MK Mbefo, KE Paleologou, A Boucharaba, A Oueslati, H Schell, ...
Journal of Biological Chemistry 285 (4), 2807-2822, 2010
2842010
c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease
AL Mahul-Mellier, B Fauvet, A Gysbers, I Dikiy, A Oueslati, S Georgeon, ...
Human molecular genetics 23 (11), 2858-2879, 2014
2292014
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo
A Oueslati, BL Schneider, P Aebischer, HA Lashuel
Proceedings of the National Academy of Sciences 110 (41), E3945-E3954, 2013
2222013
The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity
O Khalaf, B Fauvet, A Oueslati, I Dikiy, AL Mahul-Mellier, FS Ruggeri, ...
Journal of Biological Chemistry 289 (32), 21856-21876, 2014
2132014
Human-to-mouse prion-like propagation of mutant huntingtin protein
I Jeon, F Cicchetti, G Cisbani, S Lee, E Li, J Bae, N Lee, L Li, W Im, M Kim, ...
Acta neuropathologica 132, 577-592, 2016
1792016
Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's disease
A Oueslati, KE Paleologou, BL Schneider, P Aebischer, HA Lashuel
Journal of Neuroscience 32 (5), 1536-1544, 2012
1172012
Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease
MB Fares, B Maco, A Oueslati, E Rockenstein, N Ninkina, VL Buchman, ...
Proceedings of the National Academy of Sciences 113 (7), E912-E921, 2016
1142016
Chronic high‐frequency stimulation of the subthalamic nucleus and L‐DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission
P Gubellini, A Eusebio, A Oueslati, C Melon, L Kerkerian‐Le Goff, P Salin
European Journal of Neuroscience 24 (6), 1802-1814, 2006
912006
High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease
A Oueslati, V Sgambato-Faure, C Melon, P Kachidian, P Gubellini, M Amri, ...
Journal of Neuroscience 27 (9), 2377-2386, 2007
842007
Photobiomodulation suppresses alpha-synuclein-induced toxicity in an AAV-based rat genetic model of Parkinson’s disease
A Oueslati, B Lovisa, J Perrin, G Wagnières, H van den Bergh, Y Tardy, ...
PloS one 10 (10), e0140880, 2015
762015
Protein transmission, seeding and degradation: key steps for α-synuclein prion-like propagation
A Oueslati, M Ximerakis, K Vekrellis
Experimental neurobiology 23 (4), 324, 2014
692014
Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo
MK Mbefo, MB Fares, K Paleologou, A Oueslati, G Yin, S Tenreiro, ...
Journal of Biological Chemistry 290 (15), 9412-9427, 2015
642015
Dysfunction of the cortico‐basal ganglia‐cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism
A Oueslati, N Breysse, M Amalric, L Kerkerian‐Le Goff, P Salin
European Journal of Neuroscience 22 (11), 2765-2774, 2005
482005
Dissecting the molecular pathway involved in PLK2 kinase-mediated α-synuclein-selective autophagic degradation
M Dahmene, M Bérard, A Oueslati
Journal of Biological Chemistry 292 (9), 3919-3928, 2017
332017
Shedding a new light on Huntington’s disease: How blood can both propagate and ameliorate disease pathology
M Rieux, M Alpaugh, G Sciacca, M Saint-Pierre, M Masnata, HL Denis, ...
Molecular psychiatry 26 (9), 5441-5463, 2021
282021
Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies
E Lacombe, V Khaindrava, C Melon, A Oueslati, L Kerkerian-Le Goff, ...
Neurobiology of disease 36 (1), 116-125, 2009
282009
The system can't perform the operation now. Try again later.
Articles 1–20